Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Archives of Psychiatry and Clinical Neuroscience
Published in: European Archives of Psychiatry and Clinical Neuroscience 1/2012

01-02-2012 | Original Paper

Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression

Authors: Xuan Wang, Yue-Hua Li, Ming-Hua Li, Jing Lu, Jun-Gong Zhao, Xiao-Jiang Sun, Bin Zhang, Jian-Lin Ye

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 1/2012

Login to get access

Abstract

In recent studies, the glutamate (Glu) level has been quantified using the modified STEAM sequence on 3T MRI. We enrolled 15 healthy volunteers and a group of 51 patients who experienced stroke for the first time and had a good prognosis. The patients with infarction were divided into three groups according to their scores by using the DSM-IV diagnostic criteria for major depressive disorder and the 17-item Hamilton Depression Rating Scale (HDRS). We studied the association between post-stroke depression and 1H-MRS measurements in unaffected frontal lobes. Single-voxel proton magnetic resonance spectroscopy (1H-MRS) was performed to assess N-acetylaspartate/creatine (NAA)/Cr, (Glu)/Cr, choline (Cho)/Cr, and myoinositol (mI)/Cr ratios in stroke patients. The 11 patients (21.5%) who met the criteria for depression and 9 patients (17.6%) who had a high score for HDRS, (>14) but were not depressed, had a significantly higher Glu/Cr ratio than patients who scored ≤14 on HDRS and control groups (p < 0.001). No differences were found in NAA/Cr, Cho/Cr, or mI/Cr between the groups after stroke. These findings suggest that post-stroke depression is accompanied by changes in glutamate levels in the frontal lobe.
Literature
1.
2.
Singh A, Black SE, Herrmann N, Leibovitch FS, Ebert PL, Lawrence J, Szalai JP (2000) Functional and neuroanatomic correlations in poststroke depression: the Sunnybrook Stroke Study. Stoke 31(3):637–644
3.
Aström M, Adolfsson R, Asplund K (1993) Major depression in stroke patients. A 3-year longitudinal study. Stroke 24(7):976–982PubMedCrossRef
4.
Malhi GS, Valenzuela M, Wen W, Sachdev P (2002) Magnetic resonance spectroscopy and its applications in psychiatry. Aust N Z J Psychiatry 36(1):31–43PubMedCrossRef
5.
Petroff OA, Pleban LA, Spencer DD (1995) Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. Magn Reson Imaging 13(8):1197–1211PubMedCrossRef
6.
Mendes-Ribeiro JA, Soares R, Simões-Ribeiro F, Guimarães ML (1998) Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control? J Neurol Neurosurg Psychiatry 65(4):518–522PubMedCrossRef
7.
Yang S, Hu J, Kou Z, Yang Y (2008) Spectral simplification for resolved glutamate and glutamine measurement using a standard STEAM sequence with optimized timing parameters at 3, 4, 4.7, 7, and 9.4T. Magn Reson Med 59(2):236–244PubMedCrossRef
8.
Soares JC, Mann JJ (1997) The anatomy of mood disorders–review of structural neuroimaging studies. Biol Psychiatry 41(1):86–106PubMedCrossRef
9.
Kumar A, Thomas A, Lavretsky H, Yue K, Huda A, Curran J, Venkatraman T, Estanol L, Mintz J, Mega M, Toga A (2002) Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry 159(4):630–636PubMedCrossRef
10.
Beauregard M, Leroux JM, Bergman S, Arzoumanian Y, Beaudoin G, Bourgouin P, Stip E (1998) The functional neuroanatomy of major depression: an fMRI study using an emotional activation paradigm. Neuroreport 9(14):3253–3258PubMedCrossRef
11.
12.
Ochsner KN, Bunge SA, Gross JJ, Gabrieli JD (2002) Rethinking feelings: an FMRI study of the cognitive regulation of emotion. J Cogn Neurosci 14(8):1215–1229PubMedCrossRef
13.
Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337(8756):1521–1526PubMedCrossRef
14.
Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R (1989) Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 9(1):79–93PubMedCrossRef
15.
First MB, Gibbon M, Spitzer RL, Williams JB (1996) User Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders: Research Version. SCID-I, final version, version 2.0. New York State Psychiatric Institute, New York
16.
17.
Rosenberg DR, Macmaster FP, Mirza Y, Smith JM, Easter PC, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Villafuerte RA, Moore GJ, Renshaw P (2005) Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biol Psychiatry 58(9):700–704PubMedCrossRef
18.
Price RB, Shungu DC, Mao X, Nestadt P, Kelly C, Collins KA, Murrough JW, Charney DS, Mathew SJ (2009) Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder. Biol Psychiatry 65(9):792–800PubMedCrossRef
19.
Auer DP, Pütz B, Kraft E, Lipinski B, Schill J, Holsboer F (2000) Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 47(4):305–313PubMedCrossRef
20.
Levine J, Panchalingam K, Rapoport A, Gershon S, McClure RJ, Pettegrew JW (2000) Increased cerebrospinal fluid glutamine levels in depressed patients. Biol Psychiatry 47(7):586–593PubMedCrossRef
21.
Glodzik-Sobanska L, Slowik A, McHugh P, Sobiecka B, Kozub J, Rich KE, Urbanik A, Szczudlik A (2006) Single voxel proton magnetic resonance spectroscopy in post-stroke depression. Psychiatry Res 148(2–3):111–120PubMed
22.
Taylor MJ, Mannie ZN, Norbury R, Near J, Cowen PJ (2011) Elevated cortical glutamate in young people at increased familial risk of depression. Int J Neuropsychopharmacol 14(2):255–259PubMedCrossRef
23.
Hackett ML, Yapa C, Parag V, Anderson CS (2005) Frequency of depression after stroke: a Systematic Review of Observational Studies. Stroke 36(3):1330–1340PubMedCrossRef
24.
Aben I, Denollet J, Lousberg R, Verhey F, Wojciechowski F, Honig A (2002) Personality and vulnerability to depression in stroke patients: a 1-year prospective follow-up study. Stroke 33(10):2391–2395PubMedCrossRef
25.
Sappey-Marinier D, Calabrese G, Hetherington HP, Fisher SN, Deicken R, Van Dyke C, Fein G, Weiner MW (1992) Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities. Magn Reson Med 26(2):313–327PubMedCrossRef
26.
Michael-Titus AT, Bains S, Jeetle J, Whelpton R (2000) Imipramine phenelzine decrease glutamate overflow in the prefrontal cortex–a possible mechanism of neuroprotection in major depression? Neuroscience 100(4):681–684PubMedCrossRef
27.
Gruber S, Frey R, Mlynárik V, Stadlbauer A, Heiden A, Kasper S, Kemp GJ, Moser E (2003) Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest Radiol 38(7):403–408PubMed
28.
Labelle M, Khiat A, Durocher A, Boulanger Y (2001) Comparison of metabolite levels and water diffusion between cortical and subcortical strokes as monitored by MRI and MRS. Invest Radiol 36(3):155–163PubMedCrossRef
Metadata
Title
Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression
Authors
Xuan Wang
Yue-Hua Li
Ming-Hua Li
Jing Lu
Jun-Gong Zhao
Xiao-Jiang Sun
Bin Zhang
Jian-Lin Ye
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 1/2012
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-011-0209-3

Other articles of this Issue 1/2012

European Archives of Psychiatry and Clinical Neuroscience 1/2012 Go to the issue

Original Paper

Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer’s disease measured by pulsed arterial spin labeling MRI

Original Paper

Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes

Editorial

Emotional status: diagnosis and treatment for severe psychiatric disorders

Original Paper

Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders

Original Paper

Psychobiological responses to unpleasant emotions in cannabis users

Original Paper

Internet suicide searches and the incidence of suicide in young people in Japan